Chronic Obstructive Pulmonary Disease (COPD) Archives

Can we safely use betablockers in COPD?

Presented By

Dr Bryan Lipworth, University of Dundee, UK

Trial

BLOCK

Conference

ATS 2024

Type

News article

11 June 2024 10:26

COURSE: Encouraging results for tezepelumab in COPD

Presented By

Prof. Dave Singh, University of Manchester, UK

Trial

Phase 2, COURSE

Conference

ATS 2024

Type

News article

11 June 2024 10:18

Ensifentrine delays transition from GOLD B to GOLD E in COPD

Presented By

Dr Frank Sciurba, University of Pittsburgh, PA, USA

Trial

ENHANCE

Conference

ATS 2024

Type

News article

11 June 2024 10:12

NOTUS: Dupilumab safe and efficacious in COPD with type 2 inflammation

Presented By

Dr Surya Bhatt, University of Alabama at Birmingham, AL, USA

Trial

Phase 3, NOTUS

Conference

ATS 2024

Type

News article

10 June 2024 17:37

BOREAS: Blood eosinophil count and FeNO levels predictive of dupilumab response in COPD

Presented By

Dr Stephanie Christenson , University of California San Francisco, CA, USA

Trial

Phase 3, BOREAS

Conference

ATS 2024

Type

News article

10 June 2024 17:30

UCAP: Identify and treat undiagnosed COPD or asthma

Presented By

Dr Shawn Aaron, Ottawa Hospital Research Institute, Canada

Conference

ATS 2024

Type

News article

10 June 2024 17:04

Diagnostic tool doubles cardiovascular diagnoses in patients with COPD or diabetes

Presented By

Dr Amy Groenewegen, University Medical Center Utrecht, the Netherlands

Conference

ESC 2023

Type

Peer-reviewed article

30 October 2023 16:01

Practice-changing results for ensifentrine in COPD

Presented By

Prof. Antonio Anzueto, University of Texas Health San Antonio, TX, USA

Trial

Phase 3, ENHANCE-1, ENHANCE-2

Conference

ATS 2023

Type

News article

12 June 2023 16:10

Alvelestat for AATD meets primary endpoints in phase 2 trial

Presented By

Prof. Robert Stockley, University Hospital Birmingham, UK

Trial

Phase 2, ASTRAEUS

Conference

ATS 2023

Type

News article

12 June 2023 16:08

Fewer exacerbations with dupilumab in COPD with type 2 inflammation

Presented By

Prof. Klaus Rabe, LungenClinic Grosshansdorf GmbH, Germany

Trial

Phase 3, BOREAS

Conference

ATS 2023

Type

News article

12 June 2023 16:05

Efficient detection of AECOPD with at-home vital signs monitoring

Presented By

Mr Yann Le Guillou, Biosency, France

Conference

ATS 2023

Type

News article

12 June 2023 15:55

Icenticaftor achieves results on top of triple inhalation therapy in COPD

Presented By

Prof. Frits Franssen, Maastricht University, the Netherlands

Conference

ERS 2022

Type

Peer-reviewed article

30 October 2022 20:50

STARR2: A new approach for treating COPD exacerbations

Presented By

Prof. Mona Bafadhel, King’s College London, UK

Trial

Phase 4, STARR2

Conference

ERS 2022

Type

Peer-reviewed article

30 October 2022 20:48

COPD medication not effective in symptomatic smokers with preserved spirometry

Presented By

Prof. MeiLan Han, University of Michigan, MI, USA

Trial

Phase 3, RETHINC

Conference

ERS 2022

Type

Peer-reviewed article

30 October 2022 20:46

Do digital tools improve physical activity in COPD?

Presented By

Prof. Andre Nyberg, University of Umeå, Sweden

Conference

ERS 2022

Type

Peer-reviewed article

30 October 2022 20:43

Hyperpolarised gas MRI ready for clinical use

Presented By

Dr Sarah Svenningsen, McMaster University, Canada

Conference

ERS 2022

Type

Peer-reviewed article

30 October 2022 20:41

ERS 2022 Highlights Podcast

Presented By

Robert van den Heuvel, Medicom

Conference

ERS 2022

22 September 2022 02:57

Tailored exercise needed for COPD patients

Presented By

Prof. Andre Nyberg, Umea University, Sweden

Conference

NLC 2022

Type

Peer-reviewed article

17 August 2022 16:28

Effects of passive vaping in COPD patients

Presented By

Prof. Torben Sigsgaard, Aarhus University, Denmark

Conference

NLC 2022

Type

Peer-reviewed article

17 August 2022 14:32

Three’s a crowd for triple therapy in COPD

Presented By

Prof. Claus Vogelmeier, Philipps-University Marburg, Germany

Conference

ATS 2022

Type

Peer-reviewed article

18 July 2022 12:40

Higher 1-year COPD mortality after hospitalisation for White patients

Presented By

Dr Snigdha Jain, Yale School of Medicine, CT, USA

Conference

ATS 2022

Type

Peer-reviewed article

18 July 2022 12:39

CT-evident mucus plugs in COPD associated with death

Presented By

Dr Alejandro Diaz, Brigham and Women’s Hospital, MA, USA

Trial

COPDGene

Conference

ATS 2022

Type

Peer-reviewed article

18 July 2022 12:35

Home-based rehabilitation improves COPD: a randomised study

Presented By

Dr Roberto Benzo, Mayo Clinic Rochester, MN, USA

Conference

ATS 2022

Type

Peer-reviewed article

18 July 2022 12:33

No screening evidence for COPD

Presented By

Prof. Carol Mangione, University of California at Los Angeles, CA, USA

Conference

ATS 2022

Type

Peer-reviewed article

18 July 2022 11:44

JAK inhibitors and bDMARDs not associated with increased risk of serious infections in RA

Presented By

Dr Anja Strangfeld, German Rheumatism Research Centre Berlin, Germany

Conference

EULAR 2021

Type

Peer-reviewed article

2 August 2021 23:53

Possible aetiologies for COPD exacerbations – more evidence is needed

Presented By

Prof. Surya P. Bhatt, Birmingham School of Medicine, AL, USA

Conference

ATS 2021

Type

Peer-reviewed article

5 July 2021 13:50

Does COPD plus COVID-19 equal higher mortality?

Presented By

Dr Jacob Schwartz, Lenox Hill Hospital, NY, USA

Conference

ATS 2021

Type

Peer-reviewed article

5 July 2021 13:50

Biomarkers for acute exacerbations in COPD are required

Presented By

Prof. Don D. Sin, University of British Columbia, BC, Canada

Conference

ATS 2021

Type

Peer-reviewed article

5 July 2021 13:50

Severe exacerbations: A key driver of all-cause mortality in COPD patients

Presented By

Prof. Manoj J. Mammen, Jacobs School of Medicine and Biomedical Sciences, NY, USA

Trial

Phase 3, IMPACT

Conference

ATS 2021

Type

Peer-reviewed article

5 July 2021 13:50

Men and women with COPD differ in many ways

Presented By

Dr Franziska Trudzinski, University Hospital Centre Heidelberg, Germany

Trial

Cohort study, cosyconet

Conference

ATS 2021

Type

Peer-reviewed article

5 July 2021 13:50

Younger adults with COPD at higher health risk than previously thought

Presented By

Dr Alina J. Blazer, University of Toronto, ON, Canada

Conference

ATS 2021

Type

Peer-reviewed article

5 July 2021 13:50

Inflammatory disease as a risk factor for fractures

Presented By

Dr Giovanni Adami, University of Verona, Italy

Conference

ACR 2020

Type

Peer-reviewed article

18 January 2021 10:45

The role of chronic symptoms as early biomarkers of COPD development

Presented By

Dr James Allinson, Imperial College London, UK

Conference

ERS 2020

Type

Peer-reviewed article

29 October 2020 18:29

Urgent call for studies in COPD patients aged 40-60 years

Presented By

Prof. Wisia Wedzicha , Imperial College London, UK

Conference

ERS 2020

Type

Peer-reviewed article

29 October 2020 18:25

Nasal high-flow therapy: a novel treatment option for hypercapnic COPD patients

Presented By

Dr Jens Bräunlich, Kliniken Aurich-Emden-Norden, Germany

Conference

ERS 2020

Type

Peer-reviewed article

29 October 2020 18:10

Exacerbation history is a reliable predictor of future exacerbations

Presented By

Prof. Claus Vogelmeier, Philipps University of Marburg, Germany

Trial

Cohort study, AvoidEx

Conference

ERS 2020

Type

Peer-reviewed article

29 October 2020 18:07

Singing training effective as physical rehabilitation in COPD

Presented By

Prof. Uffe Bødtger, Nætved Hospital, Denmark

Conference

ERS 2020

Type

Peer-reviewed article

29 October 2020 18:02

Current prediction tools underestimate exacerbation risk of severe COPD patients

Presented By

Mr Spencer Keene, Maastricht University, the Netherlands

Trial

ECLIPSE

Conference

ERS 2020

Type

Peer-reviewed article

29 October 2020 16:57

COPD patients derive clinical benefit from β-blockers

Presented By

Dr Anne Nielsen, Zealand University Hospital, Denmark

Conference

ERS 2019

Type

Peer-reviewed article

28 November 2019 23:58

Smart shirt as a device to measure tidal volumes in real-life setting

Presented By

Ms Denise Mannée, Radboud University Medical Centre, the Netherlands

Conference

ERS 2019

Type

Peer-reviewed article

28 November 2019 22:19

COPD patients harbouring Pseudomonas Aeruginosa face high risk of hospitalisation

Presented By

Dr Josefin Eklöf, Copenhagen University Hospital, Denmark

Conference

ERS 2019

Type

Peer-reviewed article

28 November 2019 22:01

Exercise with virtual reality beneficial for COPD patients

Presented By

Dr Sebastian Rutkowski, Opole University of Technology, Poland

Conference

ERS 2019

Type

Peer-reviewed article

28 November 2019 21:21

One blood eosinophil count is sufficient to guide ICS therapy

Presented By

Prof. Mona Bafadhel, , University of Oxford, United Kingdom

Trial

IMPACT

Conference

ERS 2019

Type

Peer-reviewed article

28 November 2019 21:03

Female COPD patients frequently suffer from anxiety and depression

Presented By

Mr El-Hassane Ouaalaya, Bordeaux University, France

Conference

ERS 2019

Type

Peer-reviewed article

28 November 2019 20:05

COPD patients do not benefit from azithromycin therapy longer than a year

Presented By

Dr Sander Talman, Amphia Hospital, the Netherlands

Trial

Cohort study, COLUMBUS

Conference

ERS 2019

Type

Peer-reviewed article

28 November 2019 16:28

Pneumococcal vaccines: an effective way to reduce COPD hospitalisations

Presented By

Prof. Antoni Torres, University Hospital Clinic Barcelona, Catalonia, Spain

Trial

CAPiTA

Conference

ERS 2019

Type

Peer-reviewed article

28 November 2019 16:06

Dual bronchodilation improves ventilation dynamics in COPD patients

Presented By

Prof. Jens Hohlfeld, Hannover Medical School, Germany

Trial

Cohort study, CLAIM

Conference

ERS 2019

Type

Peer-reviewed article

28 November 2019 15:07

CORTICO-COP trial: eosinophil-guided therapy reduces systemic corticosteroid exposure

Presented By

Dr Pradeesh Sivapalan, University of Copenhagen, Denmark

Trial

CORTICO-COP

Conference

ATS 2019

Type

Peer-reviewed article

23 July 2019 23:23

Benralizumab does not ameliorate COPD exacerbations (GALATHEA/TERRANOVA trials)

Presented By

Prof. Gerard Criner, Temple University, USA

Trial

Phase 3, GALATHEA, TERRANOVA

Conference

ATS 2019

Type

Peer-reviewed article

23 July 2019 21:35

Ensifentrine for COPD maintenance treatment

Presented By

Dr Dave Singh, University of Manchester, UK

Conference

ATS 2019

Type

Peer-reviewed article

23 July 2019 20:17

Aclidinium bromide delays COPD exacerbation without increased MACE risk

Presented By

Prof. Kenneth Chapman, University of Toronto, Canada

Trial

ASCENT-COPD

Conference

ATS 2019

Type

Peer-reviewed article

23 July 2019 11:20

ICS: to use or not to use?

Presented By

Dr Gary Ferguson, Pulmonary Research Institute of Southeast Michigan, USA

Trial

KRONOS

Conference

ERS 2018

Type

Peer-reviewed article

7 November 2018 22:13

Macrolide antibiotics and trial with azithromycin

Presented By

Prof. Wim Janssens, University Hospital Leuven, Belgium

Trial

BACE

Conference

ERS 2018

Type

Peer-reviewed article

7 November 2018 20:21